About Prostate androgen-regulated mucin-like protein 1
Prostate androgen-regulated mucin-like protein 1 (PARM1) is a protein
from Homo sapiens identified by UniProt accession
Q6UWI2, 310 residues long.
MolForge cross-references it against 0 known binders and
50 disease associations.
Target properties
| Protein name | Prostate androgen-regulated mucin-like protein 1 |
| UniProt accession | Q6UWI2 |
| Gene | PARM1 |
| Organism | Homo sapiens |
| Length | 310 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (50)
Diseases linked to this target (Open Targets).
- calcium measurement · score 0.45
- nephrotic syndrome · score 0.33
- adolescent idiopathic scoliosis · score 0.33
- primary angle closure glaucoma · score 0.09
- pulmonary arterial hypertension · score 0.07
- C-X-C motif chemokine 10 measurement · score 0.03
- esterified cholesterol measurement · score 0.03
- low density lipoprotein cholesterol measurement · score 0.03
- cancer · score 0.02
- diffuse large B-cell lymphoma · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6UWI2-F1 | alphafold | PREDICTED | 52.07 | — |
Amino-acid sequence (310 residues)
MVYKTLFALC ILTAGWRVQS LPTSAPLSVS LPTNIVPPTT IWTSSPQNTD ADTASPSNGT HNNSVLPVTA SAPTSLLPKN ISIESREEEI TSPGSNWEGT NTDPSPSGFS STSGGVHLTT TLEEHSSGTP EAGVAATLSQ SAAEPPTLIS PQAPASSPSS LSTSPPEVFS ASVTTNHSST VTSTQPTGAP TAPESPTEES SSDHTPTSHA TAEPVPQEKT PPTTVSGKVM CELIDMETTT TFPRVIMQEV EHALSSGSIA AITVTVIAVV LLVFGVAAYL KIRHSSYGRL LDDHDYGSWG NYNNPLYDDS
Explore Prostate androgen-regulated mucin-like protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets